AIC
ABEO icon

AWM Investment Company’s Abeona Therapeutics ABEO Stock Holding History

AWM Investment Company’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.18M Buy
1,486,130
+683,000
+85% +$3.75M 0.8% 39
2026
Q1 		$3.6M Buy
803,130
+29,000
+4% +$145K 0.4% 61
2025
Q4 		$4.08M Buy
774,130
+227,130
+42% +$1.14M 0.39% 67
2025
Q3 		$2.89M Buy
547,000
+77,000
+16% +$488K 0.27% 79
2025
Q2 		$2.67M Buy
+470,000
New +$2.68M 0.3% 75

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AWM Investment Company's ABEO Position: Q2 2026 in Review

AWM Investment Company increased its Abeona Therapeutics (ABEO) stake by 85% in Q2 2026, buying an estimated $3.75M and bringing the position to 1,486,130 shares worth $9.18M. The position accounts for 0.8% of the portfolio, ranked #39.

AWM Investment Company first reported a position in ABEO in Q2 2025 and has held it in 5 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • AWM Investment Company held 1,486,130 shares of Abeona Therapeutics worth $9.18M as of Q2 2026.
  • AWM Investment Company bought 683,000 Abeona Therapeutics shares in Q2 2026, an estimated $3.75M.
  • Abeona Therapeutics made up 0.8% of AWM Investment Company's portfolio in Q2 2026, its #39 holding.
  • AWM Investment Company first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.